ANDREW LANDRUM: Open Payments
NPI 1346603552 · JONESBORO, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$570 in 20 payments from 6 companies in 2025. Trend: 2023 $164 · 2024 $508 · 2025 $570
Food & beverage: $570
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $324 |
| Novo Nordisk Inc | 2 | $107 |
| AstraZeneca Pharmaceuticals LP | 1 | $89 |
| Amgen Inc. | 1 | $26 |
| Genentech USA, Inc. | 1 | $21 |
| Phathom Pharmaceuticals, Inc. | 1 | $3 |
Products named: UBRELVY, QULIPTA, Wegovy, BREZTRI, ENBREL, Actemra, VOQUEZNA.
Industry payments across AR — which companies pay providers there.
